Government defers CDM Medicare item changes The concerns of GPs have been listened to, resulting in the Commonwealth delaying chronic disease management funding changes to 1 July next year.
‘Extremely concerned’: Frustration boils over amid CDM uncertainty The RACGP has demanded the Federal Government delay chronic disease management changes until funding details are clarified.
New dementia data shows proactive care planning is key Just 51% of dementia patients living in the community had a GP CDM attendance, leading one expert to call for more proactive and continuous care.
Promising new treatment for incurable prostate cancer Groundbreaking Australian research has unveiled a promising new treatment for patients with aggressive and therapy-resistant cancer.
Do some vaccinations really reduce dementia risk? There is mounting evidence vaccines can reduce the rates of dementia, but one GP says ‘the jury is still out’ on which ones are best.
Finger-prick test could screen for early Alzheimer’s Developed by Australian researchers, the first-of-its-kind handheld device is aimed at GPs and can detect disease markers in blood within minutes.
RACGP questions chronic disease funding ‘vacuum of information’ The Commonwealth has dropped new details about the revised MBS framework, but a persistent lack of funding details has GPs concerned.
Federal Government reveals long-awaited Better Access response It says the mental health system is ‘difficult to navigate’, but supported less than half of the recommendations in full.
Research finds genetic link between Alzheimer’s and heart disease It is hoped the new insights into the connection between the two conditions could significantly change patient care.
What does the mpox emergency mean for GPs? Experts are urging Australian GPs to be on the lookout for symptoms among their patients, after the outbreak was declared a global emergency.